Combination treatment with naftopidil increases the efficacy of radiotherapy in PC-3 human prostate cancer cells

Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy

(2016) Jingli Hao et al.   Oncotarget

The hedgehog inhibitor GANT61 sensitizes prostate cancer cells to ionizing radiation both in vitro and in vivo

(2016) Annelies Gonnissen et al.   Oncotarget

Sensitization of radio-resistant prostate cancer cells with a unique cytolethal distending toxin

(2015) Chih-Ho Lai et al.   Oncotarget

Redox-Mediated and Ionizing-Radiation-Induced Inflammatory Mediators in Prostate Cancer Development and Treatment

(2013) Lu Miao et al.   ANTIOXIDANTS & REDOX SIGNALING

Oral Naftopidil Suppresses Human Renal-Cell Carcinoma by Inducing G1 Cell-Cycle Arrest in Tumor and Vascular Endothelial Cells

(2013) Y. Iwamoto et al.   Cancer Prevention Research

Combination Therapy with the Histone Deacetylase Inhibitor LBH589 and Radiation Is an Effective Regimen for Prostate Cancer Cells

(2013) Weiwei Xiao et al.   PLoS One

Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis

(2012) Yujiang Fang et al.   CANCER SCIENCE

Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH)

(2011) S Ventura et al.   BRITISH JOURNAL OF PHARMACOLOGY

Naftopidil, a Selective  1-Adrenoceptor Antagonist, Suppresses Human Prostate Tumor Growth by Altering Interactions between Tumor Cells and Stroma

(2011) Y. Hori et al.   Cancer Prevention Research

Inhibition of Neurotensin Receptor 1 Selectively Sensitizes Prostate Cancer to Ionizing Radiation

(2011) N. C. K. Valerie et al.   CANCER RESEARCH

Adamantanyl-Histone Deacetylase Inhibitor H6CAHA Exhibits Favorable Pharmacokinetics and Augments Prostate Cancer Radiation Sensitivity

(2011) Zacharoula Konsoula et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts

(2011) Eirik Hagtvet et al.   Radiation Oncology

Targeting inflammatory pathways for tumor radiosensitization

(2010) Amit Deorukhkar et al.   BIOCHEMICAL PHARMACOLOGY

Predictive factors for the effect of the α1-D/A adrenoceptor antagonist naftopidil on subjective and objective criteria in patients with neurogenic lower urinary tract dysfunction

(2010) Masayuki Takeda et al.   BJU INTERNATIONAL

RelB-Dependent Differential Radiosensitization Effect of STI571 on Prostate Cancer Cells

(2010) Yong Xu et al.   MOLECULAR CANCER THERAPEUTICS

The Akt-inhibitor Erufosine induces apoptotic cell death in prostate cancer cells and increases the short term effects of ionizing radiation

(2010) Justine Rudner et al.   Radiation Oncology

SN52, a novel nuclear factor- B inhibitor, blocks nuclear import of RelB:p52 dimer and sensitizes prostate cancer cells to ionizing radiation

(2008) Y. Xu et al.   MOLECULAR CANCER THERAPEUTICS